BEPIROVIRSEN (BPV) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION CONTROLLED BY NUCLEOS(T)IDE ANALOGUE THERAPY: HBV DNA AND HBsAg LOSS 6 MONTHS AFTER END OF BPV TREATMENT (B-CLEAR STUDY)

被引：0
|
作者：
Yuen, Man-Fung
Lim, Seng Gee
Plesniak, Robert
Tsuji, Keiji
Diaconescu, Gheorghe
Gadano, Adrian C.
Asselah, Tarik
Yim, Hyung-Joon
Heo, Jeong
Rizzardini, Giuliano
Janssen, Harry L.
Popescu, Corneliu Petru
Stefanova-Petrova, Diana
Wong, Alexander
Idriz, Nevin
Pojoga, Cristina
Tanaka, Yasuhito
Janczewska, Ewa
Cremer, Jennifer
Elston, Robert
Lukic, Tamara
Maynard, Lauren
Kendrick, Stuart
Bharania, Punam
Campbell, Fiona
Paff, Melanie
Theodore, Dickens
机构：
来源：
HEPATOLOGY | 2023年 / 77卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5015
引用
收藏
页码：E129 / E130
页数：2
相关论文
共 50 条
  • [21] Use of nucleos(t)ide analogues for treating chronic hepatitis B virus (HBV) infection may result in the selection of HBV vaccine escape mutants
    Yuen, L.
    Revill, P.
    Locarnini, S.
    Sheldon, J.
    Soriano, V.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A173 - A173
  • [22] RETRACTION: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
    Sun, H.
    Liu, Y.
    Zhang, Y.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [23] PREDICTION OF HBSAG LOSS USING HBSAG DECLINE AFTER LONG-TERM VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B
    Zoutendijk, Roeand
    Hansen, Bettina E.
    van Vuuren, Anneke J.
    Boucher, Charles A.
    Janssen, Harry L.
    HEPATOLOGY, 2010, 52 (04) : 509A - 509A
  • [24] Residual Amount of HBV DNA in Serum is Related to Relapse in Chronic Hepatitis B Patients After Cessation of Nucleos(t)ide Analogs
    Jiang, Jian-ning
    Huang, Zhan-lian
    He, Li-xia
    Huang, Yue-hua
    Su, Ming-hua
    Xie, Rong
    Liang, Yan-xiu
    Fu, Wu-dao
    Huang, Xiao-hong
    Guo, Wen-wen
    Zhong, Shao-hua
    Liu, Zhi-hong
    Li, Shi-hua
    Zhu, Tuo-fu
    Gao, Zhi-liang
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (04) : 323 - 328
  • [25] EARLY ON-TREATMENT HBV RNA AND HBCRAG PROFILES PREDICT FAVOURABLE HBsAg SUPPRESSION OR SEROCLEARANCE UPON LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC HEPATITIS B INFECTION
    Mak, Lung-Yi
    Wong, Danny
    Kuchta, Alison
    Hilfiker, Martina
    Hamilton, Aaron
    Seto, Wai Kay Walter
    Yuen, Man-Fung
    HEPATOLOGY, 2021, 74 : 433A - 434A
  • [26] Serum HBV RNA levels after nucleos(t)ide analogue therapy withdrawal in HBeAg negative patients with chronic hepatitis B: results from the Toronto STOP Study
    Liem, Kin Seng
    van Boemmel, Florian
    Farag, Mina S.
    Fung, Scott K.
    Wong, David K. H.
    Yim, Colina K.
    Chen, Jiayun
    Rother, Karen
    Berg, Thomas
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2019, 70 : 614A - 614A
  • [27] A single dose of the GalNAc-siRNA, AB-729, results in prolonged reductions in HBsAg, HBcrAg, HBV DNA and HBV RNA in the absence of nucleos (t)ide analogue therapy in HBeAg negative subjects with chronic hepatitis B infection
    Gane, Edward
    Sevinsky, Heather
    Yuen, Man-Fung
    Anderson, Mark
    Cloherty, Gavin
    Thi, Emily P.
    Wattamwar, Tosh
    Sofia, Michael J.
    Gray, Kevin
    Antoniello, Deana
    Eley, Timothy
    Picchio, Gaston
    Sims, Karen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S762 - S763
  • [28] Keystone to Secure Safety After Stopping Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients
    Liu, Yen-Chun
    Jeng, Wen-Juei
    Chen, Chien-Hung
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1890 - 1891
  • [29] Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
    Wu, Liandong
    Yang, Zhenggang
    Zheng, Min
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 (05) : 255 - 265
  • [30] 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
    Gao, Li
    Hu, Yue
    Shi, Xiaofeng
    Li, Xin
    Zhang, Dazhi
    Ren, Hong
    ANNALS OF HEPATOLOGY, 2020, 19 (03) : 329 - 334
12345